Tag: Biotechnology

Phase III IMpower150 Study Showed Genentech’s Tecentriq (Atezolizumab) and Avastin (Bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Lung Cancer

South San Francisco, CA  November 29, 2017 Genentech Press Release – Data will be submitted to health authorities globally, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) – SOUTH SAN FRANCISCO, CA — 2017-11-19 00:00:00 Genentech,…

Working at Genentech: An insiders story

South San Francisco, CA   April 24, 2016   by Nicole Pieretti-Rael  PREFACE: As South San Francisco is home to the Biotech we have asked our followers to share their experiences of working in this field in our City. Naturejobs Career…

Genentech to Present New Data at AAN Showing Superior Efficacy of Investigational Medicine Ocrelizumab Versus Comparators on Disease Activity and Progression in Two Forms of Multiple Sclerosis

South San Francisco, Ca April 12, 2016  Genentech Press Release   New analyses showing superior efficacy of ocrelizumab across clinical and subclinical outcomes compared with interferon beta- 1a (Rebif®) in people with relapsing multiple sclerosis (MS) and compared with placebo…

SSF KaloBios (KBIO) Slashes 61% of Workforce, Considers Sale

South San Francisco, CA    November 8, 2015                      Re-broadcast from BioSpace November 6, 2015 By Mark Terry, BioSpace.com Breaking News Staff After a string of disappointing clinical trials, South San Francisco-based KaloBios Pharmaceuticals, Inc. (KBIO) announced yesterday that it was slashing…